UBS O'Connor’s Carney Technology Acquisition Corp. II Class A Common Stock CTAQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-390,382
Closed -$3.88M 732
2022
Q3
$3.88M Sell
390,382
-39,246
-9% -$389K 0.04% 359
2022
Q2
$4.24M Buy
+429,628
New +$4.23M 0.04% 363
2022
Q1
Sell
-422,027
Closed -$4.12M 591
2021
Q4
$4.12M Buy
422,027
+11,320
+3% +$111K 0.04% 336
2021
Q3
$4.01M Hold
410,707
0.03% 351
2021
Q2
$3.98M Hold
410,707
0.04% 319
2021
Q1
$3.98M Buy
+410,707
New +$4.14M 0.06% 314

Other funds holding CTAQ

UBS O'Connor's CTAQ Position: Q4 2022 in Review

UBS O'Connor sold out of Carney Technology Acquisition Corp. II Class A Common Stock (CTAQ) in Q4 2022, closing a stake of 390,382 shares — an estimated $3.88M sold.

UBS O'Connor first reported a position in CTAQ in Q1 2021 and held it in 6 quarters. The position peaked at $4.24M in Q2 2022. 27 funds tracked by Wall St. Rank hold CTAQ as of Q4 2022.

  • UBS O'Connor reported no remaining Carney Technology Acquisition Corp. II Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • UBS O'Connor sold 390,382 Carney Technology Acquisition Corp. II Class A Common Stock shares in Q4 2022, an estimated $3.88M.
  • UBS O'Connor first reported a position in Carney Technology Acquisition Corp. II Class A Common Stock in Q1 2021 and held it in 6 quarters.
  • UBS O'Connor's Carney Technology Acquisition Corp. II Class A Common Stock position peaked at $4.24M in Q2 2022.
  • 27 funds tracked by Wall St. Rank held Carney Technology Acquisition Corp. II Class A Common Stock as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.